Abstract
9537Background: Avelumab is a human anti–PD-L1 IgG1 antibody that showed a favorable efficacy and toxicity profile in pts with mMCC and progressive disease (PD) on or after chemotherapy (CT) in the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have